Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Evaluating the efficacy and safety of adebrelizumab for the adjuvant treatment of esophageal squamous cell cancer.
Epistemonikos ID: 18039357a59c1c001fa52364ae7da41e8de375e6
First added on: Dec 06, 2025